From Chemotherapy to Targeted Therapies: The Evolution of the Bone Cancer Drugs Market
Bone cancer remains one of the most challenging forms of oncology due to its complex diagnosis, aggressive progression, and the need for specialized treatment approaches. Advances in targeted therapies, immunotherapy, precision medicine, and supportive care are transforming treatment outcomes for patients worldwide. Pharmaceutical companies and research organizations continue to invest heavily...
0 Commentarii 0 Distribuiri 355 Views 0 previzualizare